論文

査読有り 最終著者 責任著者 国際誌
2021年1月

Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1

International Journal of Nanomedicine
  • Yiming Zhang
  • ,
  • Binshen Chen
  • ,
  • Naijin Xu
  • ,
  • Peng Xu
  • ,
  • Wenfeng Lin
  • ,
  • Chunxiao Liu
  • ,
  • Peng Huang

16
開始ページ
315
終了ページ
327
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.2147/IJN.S281710

BACKGROUND: Castration-resistant prostate cancer (CRPC) is still considered incurable, even though the mechanisms of CRPC had been extensively researched. Studies have demonstrated that exosomes in the tumor microenvironment contribute to prostate cancer development and progression. However, the role of exosomes in the process of CRPC progression has not yet been determined. METHODS: Co-culturing and exosome treatment assays combined with in vitro and in vivo assays were performed to determine the function of exosomes in the transformation of androgen-dependent prostate cancer (ADPC) cells into androgen-independent cells. Then, the mRNA expression profiles of ADPC cells and ADPC cells co-cultured with androgen-independent prostate cancer (AIPC) cell-derived exosomes were studied using microarrays. After silencing the expression of heme oxygenase-1 (HMOX1), Western blotting, quantitative real-time PCR, immunohistochemistry (IHC) studies, and MTS assay were used to confirm the mechanisms of exosome participation in CRPC progression. RESULTS: The results showed that ADPC cells acquired tolerance for androgen deprivation due to the exosome-mediated communication between cells. AIPC cell-derived exosomes promoted the transformation of ADPC cells into androgen-independent cells in vivo and in vitro. Microarray analysis revealed that HMOX1 in ADPC cells was up-regulated after treatment with AIPC cell-derived exosomes. Further results showed that HMOX1 is overexpressed in human AIPC specimens and protects ADPC cells from androgen deprivation. CONCLUSIONS: Our findings revealed that exosomes contribute to CRPC progression via promoting the transition of prostate cancer cells into an androgen-independent growth stage by activating HMOX1.

リンク情報
DOI
https://doi.org/10.2147/IJN.S281710
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33469288
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811443
ID情報
  • DOI : 10.2147/IJN.S281710
  • ORCIDのPut Code : 86654409
  • PubMed ID : 33469288
  • PubMed Central 記事ID : PMC7811443

エクスポート
BibTeX RIS